SEC FORM 4
$1,350.00
Oric Pharmaceuticals, Inc. (ORIC)
Sale of 100 shares at $13.50 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 24, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001695028-26-000008 · filed 2026-09-25 · View filing →